LIPO (Lipella Pharmaceuticals) Beginning Cash Position: $2.78 Mil (As of Sep. 2025)


What is Lipella Pharmaceuticals Beginning Cash Position?

Lipella Pharmaceuticals LIPO Beginning Cash Position is $2.78 Mil as of Sep. 2025. The stock has 1 warning sign investors should review.

Lipella Pharmaceuticals's Beginning Cash Position for the quarter that ended in Sep. 2025 was $2.78 Mil.

Lipella Pharmaceuticals's quarterly Beginning Cash Position increased from Mar. 2025 ($2.19 Mil) to Jun. 2025 ($4.23 Mil) but then declined from Jun. 2025 ($4.23 Mil) to Sep. 2025 ($2.78 Mil).

Lipella Pharmaceuticals's annual Beginning Cash Position increased from Dec. 2022 ($1.41 Mil) to Dec. 2023 ($5.12 Mil) but then declined from Dec. 2023 ($5.12 Mil) to Dec. 2024 ($3.29 Mil).

Lipella Pharmaceuticals Beginning Cash Position Related Terms

Lipella Pharmaceuticals Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Lipella Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipella Pharmaceuticals Beginning Cash Position Chart

Lipella Pharmaceuticals Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
0.03 0.61 1.41 5.12 3.29

Lipella Pharmaceuticals Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.19 1.35 2.19 4.23 2.78

Lipella Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $2.78 Mil mean?
Lipella Pharmaceuticals (LIPO) has a Beginning Cash Position of $2.78 Mil as of Sep. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Lipella Pharmaceuticals and its competitors.
Is Lipella Pharmaceuticals' Beginning Cash Position too high?
Lipella Pharmaceuticals' current Beginning Cash Position is $2.78 Mil.
How does Lipella Pharmaceuticals' Beginning Cash Position compare to IOBTQ and WINT?
Lipella Pharmaceuticals' Beginning Cash Position of $2.78 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Lipella Pharmaceuticals and its competitors. Lipella Pharmaceuticals's current Beginning Cash Position is $2.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lipella Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lipella Pharmaceuticals (LIPO) is currently considered Possible Value Trap. The stock's GF Value™ is $8.71, compared to a current price of $0.07 — trading 99.3% below its estimated fair value. The current Beginning Cash Position is $2.78 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Lipella Pharmaceuticals (LIPO), the current Beginning Cash Position is $2.78 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lipella Pharmaceuticals Business Description

Address 7800 Susquehanna Street, Suite 505, Pittsburgh, PA, USA, 15208
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410, which can be helpful in the treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.